sodium citrate

DRUG8 trials

Conditions

AnosmiaAnticoagulationApheresisAutosomal Dominant Polycystic Kidney DiseaseConotruncal Cardiac DefectsDietary SupplementsHeart Defects, CongenitalHeart Rate/Drug Effects

Early Phase 1

Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)

CompletedNCT00968565

Vanderbilt UniversityHeart Defects, Congenital, Respiratory Insufficiency

Start: 2010-01-31End: 2015-06-30Updated: 2015-06-03

Phase 1

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

CompletedNCT05067270

Eli Lilly and CompanyType 1 Diabetes Mellitus

Start: 2021-10-22End: 2021-12-06Updated: 2023-10-04

Phase 2

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

CompletedNCT04284657

University of Southern CaliforniaAutosomal Dominant Polycystic Kidney Disease

Start: 2019-01-30End: 2025-08-04Updated: 2025-08-06

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

Active, not recruitingNCT06204432

University of North Carolina, Chapel HillAnosmia, Long Haul COVID-19, Olfaction Disorders +1

Start: 2023-12-01End: 2025-12-31Target: 60Updated: 2025-02-20

Phase 4

Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation

CompletedNCT05191290

University Medical Centre LjubljanaAnticoagulation, Apheresis

Start: 2022-01-21End: 2022-12-30Updated: 2023-11-29

Unknown Phase

Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects

CompletedNCT00004361

National Center for Research Resources (NCRR)Conotruncal Cardiac Defects, Heart Defects, Congenital, Hypoparathyroidism +3

Start: 1995-07-31Target: 150Updated: 2005-06-24

Caffeine and Sodium Citrate Ingestion

CompletedNCT01591226

Swiss Paraplegic Research, NottwilDietary Supplements, Heart Rate/Drug Effects, Lactic Acid/Metabolism +2

Start: 2012-02-29End: 2012-09-30Updated: 2016-11-22

The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration

Not yet recruitingNCT06994312

The First Hospital of Jilin UniversitySepsis-induced Coagulopathy (SIC)

Start: 2025-07-01End: 2028-12-01Target: 282Updated: 2025-05-29

Related Papers

An Investigation Into Local Infusion Site Pain After Infusion of Ultra Rapid Lispro Excipients Across Sites and Depths

Journal of Diabetes Science and Technology2022-11-031 citations